94761-4SARS-CoV-2 (COVID-19) IgG Ab [Presence] in DBS by ImmunoassayActive
Term Description
Detection of SARS-CoV-2 IgG antibodies in a dried blood spot by an immunoassay method, such as enzyme-linked immunosorbent assay (ELISA) or microsphere immunofluorescence-based assay (MIA).
Source: Regenstrief LOINC
Part Description
LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV have been reported internationally, including Thailand and the United States, in due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. [PMID: 31953166] Reported illnesses have ranged from minor or no respiratory symptoms to severe acute respiratory illness and death.
The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Real time Reverse Transcription-Polymerase Chain Reaction (rRT-PCR) tests have been developed by the Centers for Disease Control and Prevention (CDC) and others for the diagnosis of 2019-nCoV. The existing 2019-nCoV primer and probe sets are designed for the universal detection of SARS-like coronaviruses and for specific detection of 2019-nCoV.[CDC: coronavirus/2019-ncov]
Source: LOINC
Fully-Specified Name
- Component
- SARS coronavirus 2 Ab.IgG
- Property
- PrThr
- Time
- Pt
- System
- Bld.dot
- Scale
- Ord
- Method
- IA
Additional Names
- Short Name
- SARS-CoV-2 IgG DBS Ql IA
- Display Name
- SARS-CoV-2 (COVID-19) IgG IA Ql (DBS)
- Consumer Name Alpha
- SARS-CoV-2 (COVID-19) IgG antibody, Dried blood spot
Ask At Order Entry
This panel contains a convenience grouping of terms for questions commonly asked when an order is placed in a public health laboratory.
LOINC | Name | R/O/C | Cardinality | Example UCUM Units |
---|---|---|---|---|
81959-9 | Public health laboratory ask at order entry panel | |||
Indent81744-5 | Submitter's laboratory test method [Type] in Specimen | |||
Indent81658-7 | Suspected organism [Identifier] in Specimen | |||
Indent86952-9 | Preliminary testing done Specimen | |||
Indent86953-7 | Preliminary testing result Specimen | |||
Indent86955-2 | Preliminary testing affected submission for further testing Specimen | |||
Indent95417-2 | Whether this is the patient's first test for condition of interest | |||
Indent95418-0 | Whether patient is employed in a healthcare setting | |||
Indent95419-8 | Whether the patient has symptoms related to condition of interest | |||
Indent11368-8 | Illness or injury onset date and time | C | ||
Indent77974-4 | Whether the patient was hospitalized for condition of interest | |||
Indent95420-6 | Whether the patient was admitted to intensive care unit (ICU) for condition of interest | |||
Indent95421-4 | Whether patient resides in a congregate care setting | |||
Indent82810-3 | Pregnancy status | C | ||
Indent30525-0 | Age | a |
Example Answer List LL2888-7
Source: Roche Diagnostics International
Answer | Code | Score | Answer ID |
---|---|---|---|
Nonreactive Copyright http://snomed.info/sct ID:131194007 Non-reactive (qualifier value) | LA15256-3 | ||
Reactive Copyright http://snomed.info/sct ID:11214006 Reactive (qualifier value) | LA15255-5 | ||
Invalid | LA15841-2 |
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.68
- Last Updated
- Version 2.69
- Order vs. Observation
- Both
Reference Information
Type | Source | Reference |
---|---|---|
Webcontent | Lab Tests Online®Copyright Copyright © 2001-2019 American Association for Clinical Chemistry | Coronavirus (COVID-19) Testing |
Member of these Panels
LOINC | Long Common Name |
---|---|
96118-5 | SARS-CoV-2 (COVID-19) Ab panel - DBS by Immunoassay |
Member of these Groups
LG51018-6 | SARSCoV2 antibody detection |
Language Variants Get Info
- zh-CNChinese (China)
- SARS 冠状病毒 2 抗体.IgG:
存在情况或阈值: 时间点: 全血.斑点: 序数型: 免疫测定法 - nl-NLDutch (Netherlands)
- SARS-CoV-2 As.IgG:
aanwezigheid: moment: gedroogde bloedspot: ordinaal: immunoassay - fr-CAFrench (Canada)
- coronavirus 2 du SRAS , IgG:
Présence-Seuil: Temps ponctuel: Sang sur papier filtre: Ordinal: IA - de-DEGerman (Germany)
- SARS Coronavirus 2 Ak.IgG:
NWSW: Pkt: Blut.Trpf: Ord: IA - it-ITItalian (Italy)
- SARS coronavirus 2 , Ab.IgG:
PrThr: Pt: Sangue.su carta da filtro: Ord: IA
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=94761-4
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © 2020 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright